Stocktoria
Crescent Capital BDC, Inc. CCAP
Crescent Capital BDC, Inc. (CCAP) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 16.55% (safety: at-risk).
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
About Crescent Capital BDC, Inc.
Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
FAQ
Is CCAP financially healthy?
Crescent Capital BDC, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does CCAP pay a dividend, and is it safe?
Yes. Crescent Capital BDC, Inc. pays a dividend yielding about 16.55% with a 196.5% payout ratio, rated “at-risk” for safety.
How profitable is CCAP?
In FY2025, Crescent Capital BDC, Inc. had a return on equity of 4.9%.
Is CCAP overvalued or undervalued?
Crescent Capital BDC, Inc. trades at about 6.1× trailing earnings — below its 10-year norm (10-year range 7.1×–10.9×, median 8.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CCAP?
The average Wall-Street price target for Crescent Capital BDC, Inc. is $14.00, about 26.4% above the recent price, from 7 analysts.
Is CCAP a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Crescent Capital BDC, Inc.: a Piotroski F-score of 4/9, a P/E of about 11.9×, a dividend yield of 16.55%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.